In years, the 18 kDa translocator protein (TSPO) emerged as an important imaging target in glioma and the in vivo detection of TSPO is feasible with positron emission tomography (PET) and single photon emission computed tomography (SPECT) ligands. This evidence concerns the gene TSPO and glioma.